According to Medicenna Therapeutics latest financial reports the cash on hand of MDNA is $24.69M, an increase of 63.60% to 2022. At the end of 2022 company had $15.09M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $24.69M | 63.60% |
2022 | $15.09M | -49.15% |
2021 | $29.68M | 7.12% |
2020 | $27.71M | 1490.10% |
2019 | $1.74M | - |